Multi-Drug Resistant Bacteria Carriage After Travel
March 18, 2018 updated by: Célia Lloret-Linares, MD PhD, Hopital Lariboisière
Multi-Drug Resistant Bacteria Carriage After Travel: Comparison Between Patients Who Have Been Hospitalized in a Foreign Country, or Not During the Previous Year
During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent).
They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent), regardless a travel in a foreign country during the past year, or not.
They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel.
The aim of the study will be to compare the rate of carriage of multi-drug resistant bacteria among previous travelers, or not.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ile-de-France
-
Paris, Ile-de-France, France, 75475
- URT, Hopital Lariboisiere
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients admitted in one of the medical Dpt of our Hospital who have travelled in a foreign country during the previous year
Description
Inclusion Criteria:
- All patients admitted in one of the medical Dpt of our Hospital who have travelled in a foreign country during the previous year
Exclusion Criteria:
- patients who were unable to give written consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multi-Drug Resistant bacteria carriage rate
Time Frame: At admission in our Hospital
|
Multi-Drug Resistant bacteria carriage assessed by rectal swab
|
At admission in our Hospital
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Pierre O Sellier, M.D., Ph.D., Hôpital Lariboisière
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 1, 2016
Primary Completion (ACTUAL)
December 1, 2016
Study Completion (ACTUAL)
December 1, 2016
Study Registration Dates
First Submitted
March 18, 2018
First Submitted That Met QC Criteria
March 18, 2018
First Posted (ACTUAL)
March 26, 2018
Study Record Updates
Last Update Posted (ACTUAL)
March 26, 2018
Last Update Submitted That Met QC Criteria
March 18, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRB after travel
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.